Biotech · Private company
Sirnaomics
Track this companyFree. Adds Sirnaomics to your Dealase workspace and tells you when its record changes.
Clinical trials111 recruiting or active
Pipeline programs11From trials and the company's site
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
Pipeline11
- STP705Phase 2 · Bowen's DiseaseClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 2 · Squamous Cell Carcinoma in SituClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 2 · Basal Cell CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 2 · KeloidClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 2 · Facial isSCCClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 2 · Hypertrophic ScarClinicalTrials.gov · fetched Nov 12, 2026
- FXI-GalNAc-siRNAPhase 1 · FXIClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 1 · Hepatocellular CarcinomaClinicalTrials.gov · fetched Nov 12, 2026
- STP705Phase 1 · Abdominal ObesityClinicalTrials.gov · fetched Nov 12, 2026
- STP707Phase 1 · Healthy SubjectsClinicalTrials.gov · fetched Nov 12, 2026
- STP707Phase 1 · Solid TumorClinicalTrials.gov · fetched Nov 12, 2026
Clinical trials11
- Single Ascending Dose of FXI-GalNAc-siRNA in Healthy SubjectsPHASE1 · ACTIVE_NOT_RECRUITING · started May 16, 2023ClinicalTrials.gov NCT05844293 · fetched Nov 12, 2026
- Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Adults With Facial isSCCPHASE1_PHASE2 · TERMINATED · started Aug 1, 2022ClinicalTrials.gov NCT05421013 · fetched Nov 12, 2026
- A Study to Evaluate Safety, Tolerability of Subcutaneous Injection in Adult Subjects Undergoing AbdominoplastyPHASE1 · COMPLETED · started Aug 1, 2022ClinicalTrials.gov NCT05422378 · fetched Nov 12, 2026
- A Study of STP707 Administered by IV in Healthy SubjectsPHASE1 · COMPLETED · started Feb 28, 2022ClinicalTrials.gov NCT05309915 · fetched Nov 12, 2026
- Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid TumorsPHASE1 · COMPLETED · started Nov 1, 2021ClinicalTrials.gov NCT05037149 · fetched Nov 12, 2026
- A Study to Evaluate Safety, Efficacy of Intralesional Injection of STP705 in Patients With isSCCPHASE2 · COMPLETED · started May 18, 2021ClinicalTrials.gov NCT04844983 · fetched Nov 12, 2026
- A Study for Safety and Efficacy Evaluation of Various Doses of STP705 in Reducing Keloid RecurrencePHASE2 · COMPLETED · started Apr 29, 2021ClinicalTrials.gov NCT04844840 · fetched Nov 12, 2026
- Safety, Tolerability, PK, Anti-Tumor Activity of STP705 in Subjects With Advanced/Metastatic or Surgically Unresectable Solid Tumors Who Are Refractory to Standard TherapyPHASE1 · COMPLETED · started Mar 1, 2021ClinicalTrials.gov NCT04676633 · fetched Nov 12, 2026
- Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With Basal Cell CarcinomaPHASE2 · COMPLETED · started Dec 28, 2020ClinicalTrials.gov NCT04669808 · fetched Nov 12, 2026
- Open Label, Dose Escalation Study for the Safety and Efficacy of STP705 in Adult Patients With isSCCPHASE1_PHASE2 · COMPLETED · started Mar 21, 2019ClinicalTrials.gov NCT04293679 · fetched Nov 12, 2026
- A Randomized Study to Evaluate the Safety and Efficacy of Various Doses of STP705 in Subjects With Hypertrophic ScarPHASE1_PHASE2 · COMPLETED · started Jan 1, 2017ClinicalTrials.gov NCT02956317 · fetched Nov 12, 2026